Q3 2025
Released Oct 21, 2025, before the open
10-Q filed Oct 21, 2025, 21 days after period end · 0000009326-25-000022
Q3 2025 · 10-Q
Revenue$267.56M$267.56M +11.5% vs Q3 2024+4.7% vs Q2 2025
Net Income$40.29M$40.29M +19.1% vs Q3 2024+5.3% vs Q2 2025
EPS Diluted$1.24$1.24 +20.4% vs Q3 2024+6.0% vs Q2 2025
Gross Profit$95,453,000+11.8%
Operating Income$54,579,000+13.7%
Operating Cash Flowderived$65,572,000+27.8%
Margins · derived
Gross margin35.7%+0.1 pt vs Q3 2024
Operating margin20.4%+0.4 pt vs Q3 2024
Net margin15.1%+1.0 pt vs Q3 2024
What the release said
The release
Same quarter
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $267.56M | $239.94M | $229.95M | $244.27M |
| Net Income | $40.29M | $33.84M | $29.08M | $25.25M |
| EPS Diluted | $1.24 | $1.03 | $0.90 | $0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Balchem Corp · CIK 9326 · Engraved from SEC EDGAR